Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
The new opportunities in medicinal chemistry of fourth-generation EGFR inhibitors to overcome C797S mutation
Jie He et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
Runping Fang et al.
NATURE COMMUNICATIONS (2021)
Characterization of ibrutinib as a non-covalent inhibitor of SRC-family kinases
Ming Guo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Paradoxical activation of c-Src as a drug-resistant mechanism
Makio Higuchi et al.
CELL REPORTS (2021)
A Radiobrominated Tyrosine Kinase Inhibitor for EGFR with L858R/T790M Mutations in Lung Carcinoma
Muammar Fawwaz et al.
PHARMACEUTICALS (2021)
Synthesis and preliminary structure-activity relationship study of 3-methylquinazolinone derivatives as EGFR inhibitors with enhanced antiproliferative activities against tumour cells
Yan Zhang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
Yi Le et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop Cysteine
Guangyan Du et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy
Adileh Ayati et al.
BIOORGANIC CHEMISTRY (2020)
Recent advances in inhibitors of C-terminal SRC kinase
Daniel P. O'Malley
FUTURE MEDICINAL CHEMISTRY (2020)
Squaramides as Bioisosteres in Contemporary Drug Design
Kylie A. Agnew-Francis et al.
CHEMICAL REVIEWS (2020)
Design, synthesis and antitumor activity of novel thiophene-pyrimidine derivatives as EGFR inhibitors overcoming T790M and L858R/T790M mutations
Zhen Xiao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Herbicides That Target Acetohydroxyacid Synthase Are Potent Inhibitors of the Growth of Drug-Resistant Candida auris
Kylie A. Agnew-Francis et al.
ACS INFECTIOUS DISEASES (2020)
SYNTHESIS AND EVALUATION OF DIAMINOPYRIMIDINE DERIVATIVES AS DUAL INHIBITORS OF EGFR AND SRC FOR ANTITUMOR TREATMENT
Longjia Yan et al.
HETEROCYCLES (2020)
Design, Synthesis and Biological Activities of Compounds Containing 1,3,4-Oxadiazole or 1,3,4-Thiadiazole
Longjia Yan et al.
CHINESE JOURNAL OF ORGANIC CHEMISTRY (2020)
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
Alexandra Canonici et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities
Marwa Ali A. Fathi et al.
BIOORGANIC CHEMISTRY (2019)
Anti-cancer effect of doxorubicin is mediated by downregulation of HMG-Co A reductase via inhibition of EGFR/Src pathway
Un-Jung Yun et al.
LABORATORY INVESTIGATION (2019)
Properties of FDA-approved small molecule protein kinase inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Clinical management of third-generation EGFR inhibitor-resistant patients with advanced non-small cell lung cancer: Current status and future perspectives
Yi-Chen Zhang et al.
CANCER LETTERS (2019)
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S
Jonas Lategahn et al.
CHEMICAL SCIENCE (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
EGFR family and Src family kinase interactions: mechanics matters?
Zhongwen Chen et al.
CURRENT OPINION IN CELL BIOLOGY (2018)
6,7-Dimorpholinoalkoxy quinazoline derivatives as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells
Yaling Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361)
Michael P. Smolinski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Recent updates on third generation EGFR inhibitors and emergence of fourth generation EGFR inhibitors to combat C797S resistance
Harun Patel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, synthesis and evaluation of azaacridine derivatives as dual-target EGFR and Src kinase inhibitors for antitumor treatment
Zhishan Cui et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, synthesis and evaluation of acridine derivatives as multi-target Src and MEK kinase inhibitors for anti-tumor treatment
Zhishan Cui et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
Yong Jia et al.
NATURE (2016)
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2015)
Activation pathway of Src kinase reveals intermediate states as targets for drug design
Diwakar Shukla et al.
NATURE COMMUNICATIONS (2014)
Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma
Maria R. Girotti et al.
CANCER DISCOVERY (2013)
Share Paper
